Insider trade

Relmada Therapeutics (RLMD): CFO bought ~$44K

Maged Shenouda, CFO at Relmada Therapeutics, bought ~$44K of Relmada Therapeutics shares.

~$44K
Approx. value · 90K sh @ $0.4854: 228K
Holds after · shares reported

Traded: May 19, 2025
Filed: May 20, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

May 16, 2025Insider · 4 peopleInsiders: 4 purchases (~$289K)
May 19, 2025 · this disclosureInsiderCFO purchased ~$44K of RLMD shares in the open market

What came next

May 19, 2025InsiderCEO purchased ~$15K of RLMD shares in the open market
May 20, 2025Insider · 2 peopleInsiders: 2 purchases (~$114K)
Aug 26, 2025InsiderCEO purchased ~$50K of RLMD shares in the open market
Aug 27, 2025InsiderCEO purchased ~$87K of RLMD shares in the open market
Aug 28, 2025InsiderCEO purchased ~$41K of RLMD shares in the open market

View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Relmada Therapeutics

OQRO holds no insider, Congress, fund or contract record for Relmada Therapeutics dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its RLMD page.

Other recent filings by Maged Shenouda, Chief Financial Officer

The full history of Maged Shenouda, Chief Financial Officer is on the profile page.

How this filing works

Explore the data

Other disclosures at Relmada Therapeutics

Everything OQRO holds on this company is on its RLMD page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data